Desvenlafaxine Tablet, Extended Release
Product Images NDC 63629-7525

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Desvenlafaxine (NDC 63629-7525). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Desvenlafaxine Figure1)

This is a table showing the Geometric mean ratio (90% CI) for different cases of Renal and Hepatic Impairment and Population Description including Gender and Age. The table shows the change relative to reference of the concentration of a certain substance.*

FDA Label Image

Figure 2 (Desvenlafaxine Figure2)

This appears to be a table of changes in pharmacokinetic parameters due to the administration of CYP3A4 inhibitors. The specific inhibitor listed is ketoconazole, and the table shows the geometric mean ratio of the maximum concentration (Cmax) and area under the curve (AUC) of the drug before and after administration. The numbers in parentheses may indicate certain confidence intervals or statistical values. Without further context or explanation, it is difficult to provide a more detailed interpretation of the data.*

FDA Label Image

Figure 3 (Desvenlafaxine Figure3)

FDA Label Image

Figure 4 (Desvenlafaxine Image4)

This appears to be a chart or graph showing the estimated proportion of patients who experience a relapse while taking Desvenlafaxine Extended-Release Tablets 50mg versus placebo, over a specific period of time (measured in days from randomization). However, without additional context or the ability to view the accompanying visual elements, it is difficult to provide further detail or analysis.*

FDA Label Image

Figure 5 (Desvenlafaxine Image5)

This text is a graph showing the estimated proportion of patients with relapse (%) over time to relapse (days from randomization) for Desvenlafaxine Extended-Release Tablets and Placebo. The graph shows values for 50, 40, 30 and 20 on the y-axis and values for 50, 100, 150 on the x-axis.*

FDA Label Image

Structure (Desvenlafaxine Structure1)

FDA Label Image

Label Image (Lbl636297525)

This is a product label for a medication called Pristiq 50mg Tablet packaged by Bryant Ranck Prepack. The label includes information on the manufacturer, package size and expiration date, National Drug Code (NDC) number, and storage instructions. There is also a warning to keep the medication out of reach of children.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.